ACL

Alchemia (ACL)

Stock Code

ACL

Stock Exchange

ax

Alchemia (ACL) is a biotechnology company. The Company’s principal activities incorporate the development of carbohydrate-based molecules for therapeutic applications, based on its drug discovery and synthesis technologies. Alchemia was listed on the Australian Stock Exchange ASX on 23rd of December, 2003. Alchemia along with its subsidiaries is engaged in the research and development of new human pharmaceuticals.

Sharemarket Monday AGMs and EGMs


Two Annual General Meetings and Extraordinary General Meetings are scheduled on Monday, December 19, 2011. Meanwhile, there will be no upcoming floats and ex-dividends.

Annual General Meeting

Sharemarket on Wednesday: Floats and Meetings


No upcoming ex-dividends are scheduled in the sharemarket world on Wednesday, November 23, 2011. On the other hand, there will be an Extraordinary General Meeting, two floats and several Annual General Meetings scheduled on the said day.

Float

Alchemia Dividends

1 September, 2010 - 13:29

Read up on the dividend history for ALCHEMIA LIMITED. Dividends are a payment declared by a company's board of directors and given to its shareholders from the company's current or retained earnings. Dividends are usually released as cash (cash dividend). Dividends provide an incentive to own shares in the company. Companies are not required to pay dividends. You are eligible to receive ACL dividends if you own the ALCHEMIA LIMITED shares on the ex-dividend date.

Alchemia Dividends

1 September, 2010 - 13:01

Read up on the dividend history for ALCHEMIA LIMITED. Dividends are a payment declared by a company's board of directors and given to its shareholders from the company's current or retained earnings. Dividends are usually released as cash (cash dividend). Dividends provide an incentive to own shares in the company. Companies are not required to pay dividends. You are eligible to receive ACL dividends if you own the ALCHEMIA LIMITED shares on the ex-dividend date.

Alchemia (ACL) Stock Recommendation


ABN Amro has rated the Alchemia (ACL) stock with a Buy and a valuation of $3.55 per share. The broker has noted that the company has also entered a collaboration with another European drug company to search for new drug candidates, providing future upside potential if any successful developments are made.

Top ASX Stock Picks for 2006: Small Caps


These are the Top ASX Stock Picks for 2006 for the Small Caps provided by ABN Amro:

CDO, TBG, ARQ, CBH, QCG, ABC, ACL, CCP, QMT, OAK.

Now, I'm not suggesting you go out and buy these top picks for the small caps stocks arena - they may look cheap, may have a lot of upside but you also have to consider what you exit plan is if you do decide to trade these small cap stocks.

Syndicate content

Recommended Websites